Skip to main content

Table 4 Correlations between changes in BACS scores and changes in SWNS scores

From: Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial

  

BACS

 

VL

WM

MoF

VF

AP

EF

COM

SWNS

TS

−.03

−.05

.03

−.24

.29

.17

.08

MeF

−.07

.13

.05

−.19

.24

.33

.21

SC

−.28

.01

.02

−.27

.06

.16

−.08

ER

.11

−.15

.23

.09

.46*

−.03

.20

PF

−.13

.03

.14

−.20

.09

.26

.14

SI

.08

−.05

.03

-.13

.23

.33

.24

  1. BACS brief assessment of cognition in schizophrenia, SWNS subjective well-being under neuroleptic drug treatment short form, VL verbal learning, WM working memory, MF motor function, VF verbal fluency, AP attention and processing speed, EF executive function, COM composite score, TS total score, MF mental function, SC self-control, ER emotional regulation, PF physical functioning, SI social integration
  2. *p < .05